ELV
Elevance Health Inc
NYSE: ELV · HEALTHCARE · HEALTHCARE PLANS
$376.42
-0.06% today
Updated 2026-04-30
Market cap
$81.74B
P/E ratio
15.95
P/S ratio
0.41x
EPS (TTM)
$23.60
Dividend yield
1.82%
52W range
$269 – $415
Volume
2.0M
Elevance Health Inc (ELV) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+11.2%
Last 4 quarters
Revenue YoY growth
+2.6%
Most recent quarter
EPS YoY growth
+5.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+3.5%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+7.5%
2026-01-28
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-22 | $12.58 | +16.4% | $328.11 | $346.29 | +5.5% |
| 2026-01-28 | $3.33 | +7.8% | $322.92 | $346.98 | +7.5% |
| 2025-10-21 | $6.03 | +22.1% | $354.07 | $345.21 | -2.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $10.81 | $12.58 | +16.4% | $50.18B | +2.6% |
| 2025-12-31 | $3.09 | $3.33 | +7.8% | $49.75B | +9.5% |
| 2025-09-30 | $4.94 | $6.03 | +22.1% | $50.71B | +12.3% |
| 2025-06-30 | $8.96 | $8.84 | -1.3% | $49.78B | +14.0% |
| 2025-03-31 | $11.48 | $11.97 | +4.3% | $48.89B | +14.8% |
| 2024-12-31 | $3.85 | $3.84 | -0.3% | $45.44B | +6.6% |
| 2024-09-30 | $9.65 | $8.37 | -13.3% | $45.15B | +5.4% |
| 2024-06-30 | $10.01 | $10.12 | +1.1% | $43.65B | — |
| 2024-03-31 | $10.53 | $10.64 | +1.0% | $42.58B | — |
| 2023-12-31 | $5.59 | $5.62 | +0.5% | $42.65B | — |
| 2023-09-30 | $8.46 | $8.99 | +6.3% | $42.85B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $26.15 | $194.8B | +-2.2% | 18 | high |
| 2027 (E) | $29.52 | $205.4B | +5.4% | 18 | high |
| 2028 (E) | $33.21 | $218.2B | +6.2% | 18 | medium |
| 2029 (E) | $37.42 | $231.8B | +6.3% | 18 | medium |
| 2030 (E) | $42.05 | $246.1B | +6.2% | 18 | medium |
Frequently asked questions
Has Elevance Health Inc beaten earnings estimates?
Elevance Health Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +11.2% over the last 4 quarters.
How does ELV stock react to earnings?
ELV stock has moved an average of +3.5% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Elevance Health Inc's revenue growth rate?
Elevance Health Inc reported year-over-year revenue growth of +2.6% in its most recent quarter, with EPS growing +5.1% year-over-year.
What is the expected EPS for ELV in 2026?
Analysts expect Elevance Health Inc to report EPS of $26.15 for fiscal year 2026, on revenue of $194.8B, based on estimates from 18 analysts.